Journal
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
Volume 12, Issue 8, Pages 10079-10092Publisher
MDPI
DOI: 10.3390/ijerph120810079
Keywords
Acinetobacter baumannii; multidrug resistance; nosocomial infections; oxacillinase; efflux pump
Funding
- Ningxia Key Laboratory of Clinical and Pathogenic Microbiology
Ask authors/readers for more resources
The objective of this study was to explore the molecular epidemiology and the genetic support of clinical multidrug resistant (MDR) Acinetobacter baumannii (A. baumannii) isolates in an ICU ward of a comprehensive hospital. A total of 102 non-duplicate drug-resistant A. baumannii isolates were identified and 93 (91.1%) of them were MDR strains. Molecular analysis demonstrated that carbapenemase genes bla(OXA-23) and bla(OXA-51) were presented in all 93 MDR isolates (100%), but other carbapenemase genes, including bla(OXA-24), bla(OXA-58), bla(IMP-1), bla(IMP-4), bla(SIM), and bla(VIM) genes were completely absent in all isolates. In addition, genes of AdeABC efflux system were detected in 88.2% (90/102) isolates. Interestingly, an addition to efflux pump inhibitor, reserpine could significantly enhance the susceptibility of MDR isolates to moxifloxacin, cefotaxime, and imipenem (p < 0.01). Clonal relationship analysis further grouped these clinical drug-resistant isolates into nine clusters, and the MDR strains were mainly in clusters A, B, C, and D, which include 16, 13, 25, and 15 isolates, respectively. This study demonstrated that clinical isolates carrying carbapenemase-encoding genes bla(OXA-23) and AdeABC efflux pump genes are the main prevalent MDR A. baumannii, and the co-expression of oxacillinase and efflux pump proteins are thus considered to be the important reason for the prevalence of this organism in the ICU of this hospital.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available